.

.,

Korean J Med > Volume 69(1); 2005 > Article

Review

The Korean Journal of Medicine 2005;69(1):150-150.

Extended study topotecan, idarubicin, and intermediate-dose cytarabine combination chemotherapy in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome

Jin Seok Kim

Abstract

TOOLS

PDF Links
Full text via DOI
Download Citation
Share :

METRICS

1,019 View
1 Download

Editorial Office: 101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791 Fax: +82-2-790-0993 E-mail: kaim@kams.or.kr